Literature DB >> 27037492

Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.

Elizabeth M van der Pijl1, Maaike van Putten2, Erik H Niks1, Jan J G M Verschuuren1, Annemieke Aartsma-Rus2, Jaap J Plomp1.   

Abstract

Duchenne muscular dystrophy (DMD) is an X-linked myopathy caused by dystrophin deficiency. Dystrophin is present intracellularly at the sarcolemma, connecting actin to the dystrophin-associated glycoprotein complex. Interestingly, it is enriched postsynaptically at the neuromuscular junction (NMJ), but its synaptic function is largely unknown. Utrophin, a dystrophin homologue, is also concentrated at the NMJ, and upregulated in DMD. It is possible that the absence of dystrophin at NMJs in DMD causes neuromuscular transmission defects that aggravate muscle weakness. We studied NMJ function in mdx mice (lacking dystrophin) and wild type mice. In addition, mdx/utrn(+/-) and mdx/utrn(-/-) mice (lacking utrophin) were used to investigate influences of utrophin levels. The three Duchenne mouse models showed muscle weakness when comparatively tested in vivo, with mdx/utrn(-/-) mice being weakest. Ex vivo muscle contraction and electrophysiological studies showed a reduced safety factor of neuromuscular transmission in all models. NMJs had ~ 40% smaller miniature endplate potential amplitudes compared with wild type, indicating postsynaptic sensitivity loss for the neurotransmitter acetylcholine. However, nerve stimulation-evoked endplate potential amplitudes were unchanged. Consequently, quantal content (i.e. the number of acetylcholine quanta released per nerve impulse) was considerably increased. Such a homeostatic compensatory increase in neurotransmitter release is also found at NMJs in myasthenia gravis, where autoantibodies reduce acetylcholine receptors. However, high-rate nerve stimulation induced exaggerated endplate potential rundown. Study of NMJ morphology showed that fragmentation of acetylcholine receptor clusters occurred in all models, being most severe in mdx/utrn(-/-) mice. Overall, we showed mild 'myasthenia-like' neuromuscular synaptic dysfunction in several Duchenne mouse models, which possibly affects muscle weakness and degeneration.
© 2016 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  acetylcholine receptor; electrophysiology; endplate; neuromuscular junction; synaptic transmission

Mesh:

Substances:

Year:  2016        PMID: 27037492     DOI: 10.1111/ejn.13249

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  25 in total

Review 1.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

2.  ActRIIB:ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders.

Authors:  Jia Li; Maureen Fredericks; Marishka Cannell; Kathryn Wang; Dianne Sako; Michelle C Maguire; Rosa Grenha; Katia Liharska; Lavanya Krishnan; Troy Bloom; Elitza P Belcheva; Pedro A Martinez; Roselyne Castonguay; Sarah Keates; Mark J Alexander; Hyunwoo Choi; Asya V Grinberg; R Scott Pearsall; Paul Oh; Ravindra Kumar; Rajasekhar Nvs Suragani
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

Review 3.  Breathing in Duchenne muscular dystrophy: translation to therapy.

Authors:  Doreen Z Mhandire; David P Burns; Angela L Roger; Ken D O'Halloran; Mai K ElMallah
Journal:  J Physiol       Date:  2022-06-24       Impact factor: 6.228

Review 4.  Alterations of neuromuscular junctions in Duchenne muscular dystrophy.

Authors:  Richard M Lovering; Shama R Iyer; Benjamin Edwards; Kay E Davies
Journal:  Neurosci Lett       Date:  2020-08-17       Impact factor: 3.046

Review 5.  Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy.

Authors:  Alicja Starosta; Patryk Konieczny
Journal:  Cell Mol Life Sci       Date:  2021-04-07       Impact factor: 9.261

6.  A Novel Striated Muscle-Specific Myosin-Blocking Drug for the Study of Neuromuscular Physiology.

Authors:  Dante J Heredia; Douglas Schubert; Siddhardha Maligireddy; Grant W Hennig; Thomas W Gould
Journal:  Front Cell Neurosci       Date:  2016-12-01       Impact factor: 5.505

7.  Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation.

Authors:  Huangfei Yu; Hongwei Xia; Qiulin Tang; Huanji Xu; Guoqing Wei; Ying Chen; Xinyu Dai; Qiyong Gong; Feng Bi
Journal:  Sci Rep       Date:  2017-01-19       Impact factor: 4.379

8.  Natural disease history of mouse models for limb girdle muscular dystrophy types 2D and 2F.

Authors:  S Pasteuning-Vuhman; K Putker; C L Tanganyika-de Winter; J W Boertje-van der Meulen; L van Vliet; M Overzier; J J Plomp; A Aartsma-Rus; M van Putten
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

9.  Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice.

Authors:  Cinzia Pisani; Georgios Strimpakos; Francesca Gabanella; Maria Grazia Di Certo; Annalisa Onori; Cinzia Severini; Siro Luvisetto; Stefano Farioli-Vecchioli; Irene Carrozzo; Antonio Esposito; Tamara Canu; Elisabetta Mattei; Nicoletta Corbi; Claudio Passananti
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-01-31       Impact factor: 5.187

10.  Natural disease history of the dy2J mouse model of laminin α2 (merosin)-deficient congenital muscular dystrophy.

Authors:  S Pasteuning-Vuhman; K Putker; C L Tanganyika-de Winter; J W Boertje-van der Meulen; L van Vliet; M Overzier; J J Plomp; A Aartsma-Rus; M van Putten
Journal:  PLoS One       Date:  2018-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.